Century Therapeutics (IPSC) FCF Margin (2022 - 2025)
Historic FCF Margin for Century Therapeutics (IPSC) over the last 4 years, with Q1 2025 value amounting to 32.15%.
- Century Therapeutics' FCF Margin rose 35686700.0% to 32.15% in Q1 2025 from the same period last year, while for Sep 2025 it was 99.71%, marking a year-over-year increase of 41433400.0%. This contributed to the annual value of 1673.84% for FY2024, which is 28936800.0% up from last year.
- According to the latest figures from Q1 2025, Century Therapeutics' FCF Margin is 32.15%, which was up 35686700.0% from 580.47% recorded in Q4 2024.
- In the past 5 years, Century Therapeutics' FCF Margin registered a high of 7815.31% during Q1 2022, and its lowest value of 23989.9% during Q2 2023.
- Over the past 4 years, Century Therapeutics' median FCF Margin value was 3579.38% (recorded in 2024), while the average stood at 4679.24%.
- Per our database at Business Quant, Century Therapeutics' FCF Margin plummeted by -214101700bps in 2023 and then surged by 204105200bps in 2024.
- Quarter analysis of 4 years shows Century Therapeutics' FCF Margin stood at 5599.81% in 2022, then crashed by -81bps to 10152.99% in 2023, then surged by 94bps to 580.47% in 2024, then surged by 94bps to 32.15% in 2025.
- Its last three reported values are 32.15% in Q1 2025, 580.47% for Q4 2024, and 3581.8% during Q3 2024.